MSD has announced interim results of a trial involving anti-PD-1 antibody KEYTRUDA (pembrolizumab) for the treatment of bladder cancer. …
Latest Video
New Stories
-
New analysis highlights political focus on PBS
March 20, 2019 - - Latest News -
A focus on new listings in the absence of anything else
March 20, 2019 - - Comment -
FDA puts 'partial clinical hold' on Australian developed cancer therapy
March 20, 2019 - - Latest News -
2019 BridgeTech Program officially underway
March 19, 2019 - -
Grattan proposes PBS savings for dental scheme
March 19, 2019 - - Latest News -
TGA: No impact on medicine supply with no-deal 'Brexit'
March 19, 2019 - - Latest News -
STA welcomes breast cancer approval
March 19, 2019 - - Latest News